advertisement
11.3.4 Betablocker (13)
Showing records 1 to 13
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker14526 Red blood cell (RBC) surface acetylcholinesterase showing a hemorheological pattern during glaucoma treatment
Cicco G; Vetrugno M; Rotelli MT; Sborgia G; Pennetta M; Vico PP; Memeo V; Nitti L; Sborgia C
Clinical Hemorheology and Microcirculation 2006; 35: 149-154
14566 Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: In glaucoma and ocular hypertension
Frampton JE
Drugs and Aging 2006; 23: 753-761
15158 Effect of timolol on central corneal thickness and endothelial cell density
Grub M; Leitritz M; Mielke J; Reinthal E; Bartz-Schmidt KU; Rohrbach JM
Klinische Monatsblätter für Augenheilkunde 2006; 223: 894-898
14489 The effect of glycine with timoptol on the rabbit IOP physiological values
Veselovsky J; Olah Z; Vesela A; Gressnerova S
Česka a Slovenska Oftalmologie 2006; 62: 247-254
14523 Prescription of ocular β-blockers in patients with obstructive pulmonary disease: Does a central electronic medical record make a difference?
Vinker S; Kaiserman I; Waitman DA; Blackman S; Kitai E
Clinical Drug Investigation 2006; 26: 495-500
14565 Travoprost/timolol
Hoy SM; Keam SJ; Keating GM
Drugs and Aging 2006; 23: 587-597
15304 Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clinical and Experimental Ophthalmology 2006; 34: 755-764
14901 Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid
Popovic Suic S; Vukojevic N; Cerovski B; Jukic T
Acta Medica Croatica 2006; 60: 101-103
14545 Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension
Suzuki Jr ER; Franklin LM; Basilio Da Silva LJ; Figueiredo CRL; Netto JA; Batista WD
Current Medical Research and Opinion 2006; 22: 1799-1805
14436 A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma
Caca I; Simsek H; Unlu K; Ari S; Keklikci U
Annals of ophthalmology (Skokie, Ill.) 2006; 38: 111-115
15244 24-Hour control with a latanoprost-timolol fixed combination vs timolol alone
Konstas AG; Lake S; Economou AI; Kaltsos K; Jenkins JN; Stewart WC
Archives of Ophthalmology 2006; 124: 1553-1557
15122 Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma
Uusitalo H; Kahonen M; Ropo A; Maenpaa J; Bjarnhall G; Hedenstrom H; Turjanmaa V
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1491-1496
15089 Practical measures. Advantages of fixed combination treatments
Denis P
Journal Français d'Ophtalmologie 2006; 29: 45-48